Clinical Efficacy and Safety of Tacrolimus in Pakistani Living Donor Liver Transplant Recipients.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To evaluate the association between tacrolimus trough levels and dosage in Pakistani patients undergoing live donor liver transplantation (LDLT), and the efficacy and adverse effects at different tacrolimus trough levels and dosages.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Coll Physicians Surg Pak

Title: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

Publisher: College of Physicians and Surgeons Pakistan

ISSN (Electronic): 1681-7168

ISSN (Print): 1022-386X

Publication date (Electronic): Nov 2019

Volume: 29

Issue: 11

Affiliations

[1 ] Department of Pharmacology and Therapeutics, Shifa College of Medicine, Shifa Tameer-e-Millat University, Islamabad, Pakistan.

[2 ] Department of Pharmacology and Therapeutics, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan.

[3 ] Department of Hepatobiliary and Liver Transplant, Shifa International Hospital, Shifa Tameer-e-Millat University, Islamabad, Pakistan.

[4 ] Department of Neurology, Shifa International Hospital, Shifa Tameer-e-Millat University, Islamabad, Pakistan.

[5 ] Medical Student, Shifa College of Medicine, Islamabad, Pakistan.

Article

Publisher Item ID: 040579197

DOI: 10.29271/jcpsp.2019.11.1048

PubMed ID: 31659960

SO-VID: 0ab71f21-f838-467f-9c4f-60bd5e8f985b

History

Data availability:

Comments

Comment on this article

scite_

Cited by 3

See all cited by